Last updated at 25 Jun 2024 06:36 PM
Director
DIN: 09430419
Chandra Prakash Singh is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at ATTENTIVA PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09430419.Chandra Prakash Singh is currently involved in 2 different roles. Their most recent position is with JCSONS ENTERPRISES PRIVATE LIMITED as a Director. The first company Chandra Prakash Singh was appointed to as a director was ATTENTIVA PHARMACEUTICALS PRIVATE LIMITED. Chandra Prakash Singh is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Chandra Prakash Singh is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at ATTENTIVA PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09430419.Chandra Prakash Singh is currently involved in 2 different roles. Their most recent position is with JCSONS ENTERPRISES PRIVATE LIMITED as a Director. The first company Chandra Prakash Singh was appointed to as a director was ATTENTIVA PHARMACEUTICALS PRIVATE LIMITED. Chandra Prakash Singh is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
10 Months 5 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| ATTENTIVA PHARMACEUTICALS PRIVATE LIMITED | Director | 10-Dec-2021 |
| JCSONS ENTERPRISES PRIVATE LIMITED | Director | 13-Jan-2023 |
| JCSONS ENTERPRISES PRIVATE LIMITED | Individual Promoter | 13-Jan-2023 |